On March 6, 2023 Reata Pharmaceuticals, Inc. (Nasdaq: RETA) ("Reata," the "Company," "our," "us," or "we"), a biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, reported that management will participate in the Barclays Global Healthcare Conference held next week, March 14-16, in Miami, Florida (Press release, Reata Pharmaceuticals, MAR 6, 2023, View Source [SID1234628209]). Manmeet Soni, Reata’s President, Chief Operating Officer, and Chief Financial Officer will be participating in a fireside chat during the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!